Q2 Holdings (QTWO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Palantir (PLTR) shares hit a new record high, and Dale Smothers calls the "difference maker" between it and competitors is how it utilizes A.I. He has a hold on the stock after its massive rally, though Dale sees Palantir leading the A.I.

Consensus calls for 45,000 vehicle deliveries in Q2; investors will focus on whether volume, mix and ASP guidance beat, meet or miss expectations.

OpenAI released two open-weight language models called gpt-oss-120b and gpt-oss-20b. They are designed to serve as lower-cost, accessible options that are easy for developers, researchers to use.

HAMILTON, Bermuda--(BUSINESS WIRE)--Assured Guaranty Ltd. (NYSE: AGO) (together with its subsidiaries, Assured Guaranty) announced that Kroll Bond Rating Agency, LLC (KBRA) has affirmed the AA+ insurance financial strength ratings of Assured Guaranty Inc. (AG) and its insurance subsidiaries, Assured Guaranty UK Limited (AGUK) and Assured Guaranty (Europe) SA (AGE). All the ratings have Stable Outlooks. In its August surveillance report affirming the AA+ ratings of AG, AGUK and AGE, KBRA cited:.

Black Stone Minerals, L.P. Common Units (NYSE:BSM ) Q2 2025 Earnings Call August 5, 2025 10:00 AM ET Company Participants H.

CareCloud, Inc. (NASDAQ:CCLD ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants A. Hadi Chaudhry - Co-CEO & Director Hadi Chaudhry - Corporate Participant Mahmud U.

Syndax Pharmaceuticals just delivered strong second quarter results, beating expectations, and management also increased its long-term market opportunity projections. Both Revuforj and Niktimvo are driving rapid revenue growth, with management now targeting $10 billion in peak sales for both drugs combined. Analysts remain bullish and profitability could arrive by FY 2028, a year earlier than consensus estimates before Q2 numbers came out.

Palantir Technologies Inc (NYSE:PLTR)'s latest quarterly results have triggered enthusiastic responses from major Wall Street analysts, who highlighted the company's accelerating growth and its leadership in enterprise AI deployment. Bank of America analysts welcomed the report, writing that Palantir is “approaching its own ‘singularity' moment this quarter.

The electric car giant saw year-over-year sales in the UK slide by nearly 60% and by 55% in Germany.

EEFT slides 4.7% after Q2 earnings miss, as rising expenses and lower intra-U.S. activity weigh on results.

CRISPR Therapeutics posts a wider second-quarter loss tied to Sirius deal costs, while Casgevy adoption gains momentum across global markets.

A weekly call turned into a celebration of heroes as staffers comfort one another through lingering trauma.

Neuronetics, Inc. (NASDAQ:STIM ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Keith J. Sullivan - President, CEO & Director Steven E.

Marriott Vacations Worldwide Corporation (NYSE:VAC ) Q2 2025 Earnings Call August 5, 2025 10:00 AM ET Company Participants Jason P. Marino - Executive VP & CFO John E.

Encompass Health Corporation (NYSE:EHC ) Q2 2025 Earnings Conference Call August 5, 2025 10:00 AM ET Company Participants Douglas E. Coltharp - Executive VP & CFO Mark Miller - Senior Vice President of Investor Relations & Strategic Planning Mark J.

For steady sources of income, investors can use ETFs to diversify into hundreds of reliable dividend-paying stocks.

Jim Cramer likes these dividend stocks for 2025. All three dividend stocks are solid financially and pay good yields.

O's Q2 results may show stable earnings as high occupancy, strategic deals and sector expansion support revenue growth.

PFE posts strong Q2 results with earnings up 30% and revenues up 10% year over year, fueled by rising oncology sales and cost cuts.